tilray
tilray · page 2
- Uncategorized
Young US Women Overtake Men in Cannabis Consumption for the First Time, and Retailers Are Rethinking Their Strategies
Young US women are consuming more cannabis than men for the first time, according to recently published data from the US National Institute on Drug Abuse (NIDA).
- Uncategorized
Canadian Medical Cannabis Clinic Launches 3000-Participant Study into Emerging Cannabis Treatments
Canadian medical cannabis clinic Santé Cannabis has started recruitment for a new study assessing the effectiveness of various cannabis treatment plans.
- Uncategorized
Tilray’s Cannabis Revenues Drop 13% in Q1 as Alcohol Sales Nearly Double
Tilray’s cannabis revenues fell sharply over its first quarter, but its overall revenues were up 13% thanks to a near doubling in revenues from its alcohol business.
- Uncategorized
Canadian Cannabis Sales Continue Turbulent Year With 2% Downturn in June
Canadian cannabis sales have continued their mixed performance through June 2024, seeing another dip in total sales, but some states are showing resilience.
- Cultivation
Germany’s Domestic Cannabis Cultivation Market Poised for Significant Growth as 3 New Licences Issued
Germany’s Federal Institute for Drugs and Medical Devices (BfArM) has now issued the first three new licences for domestic cannabis cultivation, expected to see the amount of product grown in the country at least double this year.
- Markets & Stocks
Tilray Gets First New German Domestic Cultivation Licence, Dalgety Seeks £6m Investment, & More from Celadon
Tilray [stock_market_widget type=”chart” template=”line” assets=”TLRY” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] US cannabis giant Tilray has become the first company in half a decade to recieve a new domestic cannabis cultivation licence in Germany.
- Uncategorized
New Tilray Study Shows Significant Pain and Sleep Improvements with Medical Cannabis in Seniors
Tilray’s medical cannabis division has today published a new scientific study showing significant improvements in pain, sleep and quality of life in patients over 50.
- Uncategorized
Canadian Retail Chain Four20 Announces Plans to File for Bankruptcy
Canadian cannabis retail chain Four20 Premium Markets, one of the largest dispensaries in Alberta, has announced plans to file for bankruptcy.
- Medical
Portugal’s Medical Cannabis Regulator Approves First New Preparations Since 2021
Portugal’s cannabis regulator has approved three new cannabis preparations for its medical cannabis programme, marking the first expansion since 2021.
- Markets & Stocks
Ananda Announces ‘Drug Supply Agreement’, Stenocare Launches 3rd Oil in Denmark, & German Stocks React to CanG Progress
Ananda Developments Ananda Developments has seen its stock increase over 5% this week after signing a ‘Drug Supply Agreement’ (DSA) with the University of Edinburgh (UOE) and NHS Lothian.
- Opinion
Czech Republic vs. Portugal: Unraveling the Unique Trajectories of Their Cannabis Markets
The Czech Republic and Portugal are two of the European cannabis industries’ most crucial markets.
- Uncategorized
Tilray Sees Stock Fall 10% Despite Record Revenues in Q2
Tilray has reported another quarter of record sales while beating analysts’ estimates on its earnings, reducing its losses by around US$15m year-on-year.
